TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate
Author(s) -
Leandro Venturutti,
Matt Teater,
Andrew Zhai,
Amy Chadburn,
Leena Babiker,
Daleum Kim,
Wendy Béguelin,
Tak C. Lee,
Youngjun Kim,
Christopher R. Chin,
William T. Yewdell,
Brian Raught,
Jude M. Phillip,
Yanwen Jiang,
Louis M. Staudt,
Michael R. Green,
Jayanta Chaudhuri,
Olivier Elemento,
Pedro Farinha,
Andrew P. Weng,
Michael Nissen,
Christian Steidl,
Ryan D. Morin,
David W. Scott,
Gilbert G. Privé,
Ari Melnick
Publication year - 2020
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2020.05.049
Subject(s) - biology , germinal center , bcl6 , reprogramming , transcription factor , phenotype , somatic hypermutation , cancer research , cell fate determination , somatic cell , lymphoma , b cell , cell , microbiology and biotechnology , gene , genetics , immunology , antibody
The most aggressive B cell lymphomas frequently manifest extranodal distribution and carry somatic mutations in the poorly characterized gene TBL1XR1. Here, we show that TBL1XR1 mutations skew the humoral immune response toward generating abnormal immature memory B cells (MB), while impairing plasma cell differentiation. At the molecular level, TBL1XR1 mutants co-opt SMRT/HDAC3 repressor complexes toward binding the MB cell transcription factor (TF) BACH2 at the expense of the germinal center (GC) TF BCL6, leading to pre-memory transcriptional reprogramming and cell-fate bias. Upon antigen recall, TBL1XR1 mutant MB cells fail to differentiate into plasma cells and instead preferentially reenter new GC reactions, providing evidence for a cyclic reentry lymphomagenesis mechanism. Ultimately, TBL1XR1 alterations lead to a striking extranodal immunoblastic lymphoma phenotype that mimics the human disease. Both human and murine lymphomas feature expanded MB-like cell populations, consistent with a MB-cell origin and delineating an unforeseen pathway for malignant transformation of the immune system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom